Trending Now
BUSINESS
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed...
MEDICAL DEVICES
MANUFACTURING
GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells...
San Antonio, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) --
GenCure, a subsidiary of BioBridge Global, today opened the first phase of a new biomanufacturing center...
JOURNAL SPOTLIGHT
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like...
Amniogenesis—the development of amnion—is a critical developmental milestone for early human embryogenesis and successful pregnancy1, 2. However, human amniogenesis is poorly understood due to...